13 October 2022 | Geneva: A meeting of a subgroup of WHO’s Global Task Force on TB Impact Measurement was held in Geneva on 28–29 September to review draft content that has been developed for the new guidance on national TB prevalence surveys. The meeting brought together global experts in the design, implementation, analysis and/or reporting of national TB prevalence surveys, including people from national TB programmes, universities, national institutes and technical agencies, as well as independent consultants. Content related to screening and diagnostic algorithms, case definitions, diagnostic investigations, documents and data management, chest radiography and clinical management was discussed. Planned next steps include the update and finalization of the document with the targeted publication date in mid-2023.

The framework is meant to address the limited uptake of collaborative activities to reduce the burden of TB and comorbidities and to support countries in enabling access to people-centred care.

The Department of Immunization, Vaccines and Biologicals (IVB) at the World Health Organization (WHO) released a draft document for public consultation 'WHO Evidence Considerations for Vaccine Policy Development (ECVP) for Tuberculosis vaccines intended for Adults and Adolescents'.

The World Health Organization releases updated guidelines and a new operational handbook on tests for the diagnosis of TB infection.

The World Health Organization (WHO)’s Global TB Program will conduct a free post-graduate course on the latest TB guidelines and recommendations on 13 October 2022 as part of the 53rd Union World Conference on Lung Health (Union Conference).

On 20 September 2022, the Government of Indonesia and the World Health Organization (WHO) hosted a high-level side event: 'Progress and multisectoral action towards achieving global targets to end TB' in the margins of the 77th Session of the United Nations General Assembly (UNGA 77).

The 72nd session of the World Health Organization (WHO) Regional Committee for Europe, held on 12–14 September 2022 in Tel Aviv, Israel, endorsed TB action plan for the WHO European Region 2023–2030, outlining the vision and strategic actions for the region.

WHO Director-General and WHO Civil Society Task Force on TB release a joint statement setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.

The World Health Organization (WHO) will host a webinar on 6 September 2022 to present the updated Guidance for national strategic planning for TB, and share perspectives and experiences from countries, civil society and partners.

The World Health Organization (WHO) is releasing new guidance to support national strategic planning for the tuberculosis (TB) response. The guidance encourages the use of a people-centeric focus in the development of national TB strategic plan (NSP). It highlights the importance of government stewardship and ownership, promotes alignment with national health strategy and other health programmes, emphasizes multi stakeholder and multi-sectoral engagement as one of the key steps for multisectoral accountability for TB.